Stimulation of Mesothelial Cells Proliferation by Endogenous Growth Factor(s)

1991 ◽  
Vol 11 (3) ◽  
pp. 228-232 ◽  
Author(s):  
Andrzej Breborowicz ◽  
Helen Rodela ◽  
Jim Pagiamtzis ◽  
Dimitrios G. Oreopoulos

We have attempted to determine whether human mesothelial cells (MC) have the power to influence their own proliferation. A serum -free medium was conditioned with the mesothelial monolayer for 24 hours and then applied to proliferating MC. Conditioned medium increased proliferation rate of MC. When the medium was heated at 60°C for 60 minutes, the growth-promoting activity of the conditioned medium decreased by 50%, suggesting that MC produce at least 2 growth factors, 1 heat-Iabile and the other heat-stable. When MC were exposed continuously to a medium containing 90 mM glucose growth factor, production was decreased by 35%. However, when the cells were exposed to glucose only on alternate days, growth-factor production was similar to that in the control medium. On the other hand, MC exposed continuously for 10 days to 90 mM of glucose exhibited a weaker response to endogenous growth factor, even in a normotonic medium with low glucose concentration. Our results suggest that MC syn thesize factor(s), which stimulate their own proliferation, and that high glucose concentrations interfere with this production and the subsequent action of growth factor.

1987 ◽  
Vol 23 (11) ◽  
pp. 1752 ◽  
Author(s):  
B.I. Gerwin ◽  
J.F. Lechner ◽  
R. Reddel ◽  
C. Betsholtz ◽  
A. Roberts ◽  
...  

1988 ◽  
Vol 7 (4) ◽  
pp. 606-610 ◽  
Author(s):  
Ramesh K. Zacharias ◽  
Thomas R. Kirkman ◽  
Richard D. Kenagy ◽  
Daniel F. Bowen-Pope ◽  
Alexander W. Clowes

2016 ◽  
Author(s):  
Artem Kaznatcheev ◽  
Robert Vander Velde ◽  
Jacob G. Scott ◽  
David Basanta

AbstractBackgroundTumours are diverse ecosystems with persistent heterogeneity in various cancer hallmarks like self-sufficiency of growth factor production for angiogenesis and reprogramming of energy-metabolism for aerobic glycolysis. This heterogeneity has consequences for diagnosis, treatment, and disease progression.MethodsWe introduce the double goods game to study the dynamics of these traits using evolutionary game theory. We model glycolytic acid production as a public good for all tumour cells and oxygen from vascularization via VEGF production as a club good benefiting non-glycolytic tumour cells. This results in three viable phenotypic strategies: glycolytic, angiogenic, and aerobic non-angiogenic.ResultsWe classify the dynamics into three qualitatively distinct regimes: (1) fully glycolytic, (2) fully angiogenic, or (3) polyclonal in all three cell types. The third regime allows for dynamic heterogeneity even with linear goods, something that was not possible in prior public good models that considered glycolysis or growth-factor production in isolation.ConclusionThe cyclic dynamics of the polyclonal regime stress the importance of timing for antiglycolysis treatments like lonidamine. The existence of qualitatively different dynamic regimes highlights the order effects of treatments. In particular, we consider the potential of vascular renormalization as a neoadjuvant therapy before follow up with interventions like buffer therapy.


Sign in / Sign up

Export Citation Format

Share Document